DRI vs TERN · P/E 22, rev $12.08B vs $6.12B cap
Darden Restaurants Inc (DRI) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. TERN currently screens at market cap $6.12B.
Not investment advice. Open the DRI and TERN stock pages for the full models.
Not investment advice.